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Abstract
Host DNA repair enzymes have long been assumed to play a role in HIV replication, and many different DNA repair factors
have been associated with HIV. In order to identify DNA repair pathways required for HIV infection, we conducted a
targeted siRNA screen using 232 siRNA pools for genes associated with DNA repair. Mapping the genes targeted by
effective siRNA pools to well-defined DNA repair pathways revealed that many of the siRNAs targeting enzymes associated
with the short patch base excision repair (BER) pathway reduced HIV infection. For six siRNA pools targeting BER enzymes,
the negative effect of mRNA knockdown was rescued by expression of the corresponding cDNA, validating the importance
of the gene in HIV replication. Additionally, mouse embryo fibroblasts (MEFs) lacking expression of specific BER enzymes
had decreased transduction by HIV-based retroviral vectors. Examining the role BER enzymes play in HIV infection suggests
a role for the BER pathway in HIV integration.
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Introduction
The retroviral life cycle requires that viral proteins co-opt host
factors to support virus production. Following HIV entry which is
initiated by the virus binding to the CD4 and either CXCR4 or
CCR5 co-receptors, the viral capsid enters the cytoplasm, viral
RNA is then uncoated and reverse transcribed, and the reverse
transcribed viral DNA is imported to the nucleus and integrated
into the host genome. The processes of reverse transcription and
integration are likely to require host DNA repair pathways at
various steps. Reverse transcription is discontinuous; primers must
be excised and discontinuities in the viral DNA must be repaired
[1]. Integration of the viral DNA into host chromatin produces a
gapped intermediate with unjoined viral 59 ends [2]. In both cases,
these gaps and discontinuities have long been assumed to be
repaired by host DNA repair pathways, but the nature of these
pathways has remained elusive.
The discovery of RNA interference has allowed loss of function
phenotypes for large numbers of genes to be screened in a single
experiment. With this technology, arrays of double stranded, 19–
21 nt RNAs can be designed to knock down the mRNA level of a
targeted gene, allowing a rapid assessment of the effect of a loss of
gene function on a specific cell phenotype following siRNA
transfection [3], [4].
Recently, a number of genome scale siRNA screens were
conducted that together identified over 1000 different host factors
associated with HIV replication, including a number of DNA
repair factors [5]–[7]. Reasoning that a smaller scale, targeted
screen might provide better focus on specific pathways of interest,
we screened an siRNA library targeting DNA repair genes for
effects on HIV replication. We identified a number of genes
involved in the short patch Base Excision Repair (BER) pathway, a
DNA repair pathway responsible for repairing damage triggered
by oxidation or alkylation of single nucleotides [8].
Results
Screening of an siRNA library targeting DNA repair genes
reveals the importance of BER factors in HIV infection
To identify DNA repair mechanisms associated with retroviral
infection, we transfected an siRNA library targeting 232 DNA
repair genes (GO:0006281) (Table S1) into HeLa P4/R5 cells.
siRNAs targeting Cyclin T1 and CDK9 were used as positive
controls for inhibition of HIV infection, and an siRNA targeting
luciferase and mock transfection as negative controls. The cells
were infected with HIV HXB2 and assayed for b-galactosidase
expression as a reporter for successful infection 48 h later [5]. The
positive control siRNAs resulted in a 40 to 50% decrease
(Figure 1A); thus, we elected to evaluate more fully all siRNAs
that resulted in more than 40% inhibition of HIV infection.
After screening the library in duplicate, we identified 41 siRNA
pools that lowered HIV infection. Six of these decreased cell
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targets were mapped to DNA repair pathways by GO annotation
(Figure 1B, Table S2). Strikingly, the non-homologous end joining
pathway (NHEJ), which has frequently been linked to HIV
replication, was represented by only one of the hits in this screen.
In contrast, 23% of the mapped genes were associated with the
base-excision repair (BER) pathway (Figure 1B, Table S2) [9]–
[12]. Since the largest number of mapped genes were assigned to
the BER pathway, we elected to examine the role of this pathway
in HIV infection further.
The results from the primary screen indicated that siRNAs
targeting a number of genes in the BER pathway decrease HIV
infection. To confirm the specificity of the siRNA pools identified
in the screen and to control for off-target silencing, we evaluated
the efficacy of the single siRNAs in each of the effective siRNA
pools identified in the BER pathway, and found at least two
effective single siRNAs targeting each of the BER genes identified
in the screen. We then probed the pathway further, and evaluated
the efficacy of single siRNAs targeting genes associated with BER
that were not identified in the screen. We found that two or more
separate single siRNAs targeting MUTYH, NTHL1, NEIL3,
XRCC1, LIG3, and POLB were capable of reducing HIV
infection by at least 40%, further implicating BER as a pathway
important for HIV replication.
The BER pathway is outlined in Figure 1C (modeled as in ref
[13]). BER is initiated when a DNA damage-sensing protein
Figure 1. siRNA screen for DNA repair factors associated with HIV infection revealed a role for the BER pathway. (A) Data from siRNA
screen represented relative to the negative control (N=2). The green squares represent control siRNAs. Negative controls were luciferase
(nonsilencing siRNA) and mock (no siRNA). Positive controls were siRNAs targeting CDK9 and Cyclin T1 (CycT1). The black squares represent siRNAs
that do not target the BER pathway. The blue squares represent siRNAs targeting genes in the BER pathway. The horizontal line running across the
graph indicates 40% inhibition; siRNAs that resulted in less than 40% infectivity were considered to be hits in the screen. (B) DNA repair pathways
targeted by effective siRNAs (BER, base excision repair; NER, nucleotide excision repair; NHEJ, non-homologous end joining; SSBR, single stranded
break repair; DSB, double stranded break repair; MMR, mismatch repair; HR, homologous recombination). The number of hits assigned to each
pathway is indicated. Of the 35 non-toxic siRNA pools that led to 40% or greater inhibition of HIV infectivity in the primary screen, 8 mapped to BER, 5
mapped to NER, 1 mapped to NHEJ, 1 mapped to SSBR, 3 mapped to DSB, 2 mapped to MMR, 6 mapped to HR. The remaining 9 could not be
mapped to specific DNA repair pathways and are not included in the diagram. (C) Diagram of the BER pathway based on [13]. siRNAs targeting BER
factors colored yellow decreased HIV infectivity by at least 40%, siRNAs targeting BER factors colored red increased HIV infectivity by at least 26.
siRNAs targeted BER factors colored blue had no effect on HIV infection.
doi:10.1371/journal.pone.0017612.g001
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two distinct mechanistic pathways termed ‘‘short patch’’ and ‘‘long
patch’’ BER [14]. In both pathways, the damaged base is removed
by a glycosylase, creating an abasic (AP) site. The glycosylase may
be a monofunctional glycosylase, associated with both short and
long patch repair, or a bifunctional glycosylase/b-lyase, associated
with short patch repair only. Of the monofunctional glycosylases,
only siRNAs targeting MUTYH decreased HIV infection. In
contrast, siRNAs targeting six different bifunctional glycosylase/b-
lyase enzymes inhibited HIV infection by at least 50% (Figure 1C
and Table 1).
Following cleavage of the phosphodiester bond 39 to the AP site,
the endonuclease APEX1 cleaves the phosphodiester bond 59 to
the site, liberating the 39 sugar residue and creating a gap. siRNAs
targeting APEX1 inhibited HIV infection by more than 60%. In
the short patch BER process, APEX1 recruits POLB to fill in the
single nucleotide gap, and the DNA backbone is then repaired by
an enzymatic complex including LIG3 and XRCC1. siRNAs
targeting POLB, LIG3, and XRCC1 inhibited HIV infection by
more than 50%. Although long path BER enzymes have been
used to model repair of HIV integration intermediates in vitro
[15], siRNAs targeting these genes had little effect on HIV
infection (Figure 1C and Table 1).
Confirmation of the specificity of BER targeting siRNAs by
cDNA rescue of the defect in HIV infection
We then validated the role of BER in HIV replication by
demonstrating rescue of the siRNA-induced knockdown pheno-
type with expression of the targeted cDNA. siRNAs targeting the
39 UTR of seven of the BER genes identified in our screen were
evaluated for both mRNA knockdown and effects on HIV
infectivity (Table 2). As shown in Table 2, we observed lowered
mRNA levels and decreased HIV infectivity following transfection
of at least two of the 39UTR directed siRNAs targeting each of the
seven BER genes, with the exception of OGG1, where, despite our
ability to identify at least two effective siRNAs targeting the coding
region of the mRNA, only one of the 39UTR directed siRNAs
reduced HIV infectivity by 50%.
Effective siRNAs were co-transfected into HeLa P4/R5 cells
along with either an empty expression vector, or the vector
expressing a cDNA for the targeted gene lacking the 39UTR
which was thus not affected by the introduction of the siRNA
(Figure 2). We observed a significant increase in HIV infectivity
upon cDNA rescue of siRNA knockdown for MUTYH, NTHL1,
LIG3 and APEX1 (p,0.01), as well as with NEIL2 and POLL
(p,0.05). Rescue with OGG1 did not reach statistical significance.
Additionally, we earlier demonstrated that siRNAs targeting the
39UTR of the b-lyase NEIL3 could effectively knock down NEIL3
mRNA levels and HIV infection of HeLa P4/R5 cells, and that
the decrease in HIV infection could be rescued by NEIL3 cDNA
expression [5]. Overall, the rescue of HIV infection by eight
different BER cDNAs suggests a role for BER in HIV infection.
Knockout of BER enzymes reduces HIV infection
The results of the siRNA screen were confirmed and extended
with murine embryonic fibroblast cell lines (MEFs) from
genetically defined BER deletion mice [16]–[19] (Figure 3). Wild
type and BER null MEFs were infected with an HIV based
retroviral vector expressing GFP following integration. Similar to
the siRNA experiments, deletion of MUTYH, OGG1, and POLB
led to decreased HIV infection (Figure 3A). In addition, infection
of NEIL1 null MEFs indicates that this glycosylase plays a similar
role in the HIV life cycle (Figures 3A and B). Expression of one
allele at least partially restored HIV infection efficiency in NEIL1
heterozygous cells (Figure 3B). Cells with a complete deletion of
OGG1 and MUTYH had less HIV infection than either
heteroallelic deletion of OGG1 or MUTYH, indicating that these
BER genes play non-redundant roles in the HIV life cycle. The
decreased infection of BER null MEFs with an HIV-based
retroviral vector supports the observations from the siRNA screen
linking BER to HIV replication.
BER is important for HIV vDNA integration
We sought to understand the requirement for BER within the
HIV life cycle by evaluating HIV entry, reverse transcription, and
transcription in HeLa P4/R5 cells transfected with siRNAs
targeting BER genes. Assays for HIV entry, tat-mediated
transcription, and reverse transcription were carried out as
described [20], [5], [21]. siRNAs targeting CD4 and CXCR4
Table 1. Effect on HIV infectivity of siRNAs targeting BER-
pathway genes.
Base-Excision
Repair Genes Role in BER
Effect of siRNAs
on HIV Infection
(% of Control)
APTX Bridge 221
PARP1 Damage sensor 30
DDB2 DNA binding 30
RPA2 DNA binding 38
APEX1 Endonuclease 36
MBD4 Glycosylase 124
MPG Glycosylase 84
TDG Glycosylase 164
UNG Glycosylase 138
UNG2 Glycosylase 131
MUTYH Glycosylase 39
ERCC5 Short patch: promotes
NTHL1 DNA binding
163
ERCC6 Helicase 74
FEN1 Long Patch 107
HMGB2 Long Patch 119
LIG1 Long Patch 119
PCNA Long Patch 209
POLD1 Long Patch Polymerase 185
POLE Long Patch Polymerase 36
APEX2 Long Patch Endonuclease 158
NEIL1 Short patch b-lyase 135
NEIL2 Short patch b-lyase 32
NEIL3 Short patch b-lyase 30
NTHL1 Short patch b-lyase 47
OGG1 Short patch b-lyase 45
POLI Short patch b-lyase 16
POLL Short patch b-lyase 22
EP300 Reduces POLB activity 264
LIG3 Short patch ligase 42
POLB Short patch polymerase 42
XRCC1 Short patch–binds LIG3 45
doi:10.1371/journal.pone.0017612.t001
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decreased the entry of virus-like particles 79 and 67%, respective-
ly. An siRNA targeting Cyclin T1 was included as a positive
control in the Tat-mediated transcription assay, and knocked
down tat-mediated transactivation of the HeLa P4/R5 LTR-
bGAL reporter construct by 64%. As shown in Table 3, we did
not observe consistent effects on viral entry, tat-mediated
transcription, or reverse transcription following HIV infection of
HeLa P4/R5 cells transfected with siRNAs targeting any of the
BER enzymes assessed (Table 3).
Following reverse transcription, HIV vDNA is transported to
the nucleus where it is integrated into host DNA. 2LTR circles are
the products of abortive retroviral integration efforts within the
nucleus, and the production of these circles can be increased by
treating HIV-infected cells with integrase inhibitors [22]. We
found that transfecting HeLa P4/R5 cells with siRNAs targeting
MUTYH, NTHL1, NEIL3 or POLB did not decrease 2LTR
circle formation, suggesting that these genes may not play a role in
nuclear localization of HIV DNA or in 2LTR circle formation
(Figure 4A).
Once the vDNA has entered the nucleus, it is integrated into
host chromosomal DNA. We measured the relative level of
integrated vDNA in cells treated with siRNAs targeting BER genes
using Alu-LTR qPCR [21]. HeLa P4/R5 cells transfected with
siRNAs targeting MUTYH, NTHL1, NEIL3, or POLB consis-
tently had 40–70% less integrated HIV DNA than cells transfected
with LUC siRNA (Figure 4B). Expression of BER pathway
enzymes thus appears to be required for successful completion of
HIV vDNA integration.
Discussion
We and others have shown that genome scale siRNA screens
can identify hundreds of host factors necessary for robust HIV
replication [5]–[7]. Here, we elected to carry out a focused siRNA
screen to address the specific question of which DNA repair
pathways are required for HIV replication. The use of a small
siRNA library targeting a particular cellular function allowed for
screening in duplicate, more in depth follow up of effective
siRNAs, and the use of bioinformatic tools to identify pathways
over-represented in the pool of hits.
Comparing our results with a targeted siRNA screen to those
of genome scale screens reveals that although the genome scale
screens all identified DNA repair factors, there was no overlap in
the specific DNA repair factors identified, and no indication of
which DNA repair pathway(s) may be most relevant for HIV
replication. We identified ERCC3 [6], BTG2, MUS81 [7] and
PMS2L1 [5] in common with the three previous genome scale
screens (Figure 5). ERCC3, the single DNA repair factor included
in our library that was identified by Brass et al [6] was also
identified in our screen. Konig et al [7] identified ten DNA repair
genes targeted in our siRNA library (BTG2, EP300, ERCC1,
ERCC5, GTF2H2, MRE11A, MUS81, RAD21, UBE2B and
XAB2). We also identified BTG2 and MUS81-targeting siRNAs
as inhibitors of HIV replication, although we found that
transfection of siRNAs targeting EP300, GTF2H2 and UBE2B
enhanced HIV infection by at least two-fold, and we did not see a
robust effect with siRNAs targeting any of the remaining genes.
Comparing the screen reported here with our own genome scale
screen [8], we previously reported a decrease in HIV infection
following transfection with five siRNA pools targeting DNA
repair enzymes, two of which were only effective at 96 h post-
infection. Of the three remaining targeted mRNAs, (PMS2L1,
MRE11A, and BRCA1), the pool targeting PMS2L1 was a strong
inhibitor of HIV infection, as it was in the genome scale study,
while neither the MRE11A nor the BRCA1 siRNA pools were
effective. However; neither of the siRNA pools targeting
MRE11A and BRCA1 used in this study included the same
siRNA sequences used in the genome scale screen, and
differences in siRNA efficacy may explain the discrepancy
between the results. Comparing the data from the DNA repair
focused screen to that generated in genome scale screens, it is
clear that by focusing on a smaller set of genes in this targeted
screen, we were able to reproduce some of the results from
previous screens. Moreover, we observed more overlap with these
screens than they had with each other, and we were able to
extend the general observation that DNA repair is important to
HIV infection by pinpointing a pathway of interest.
Somewhat surprisingly, the DNA repair pathway most fre-
quently associated with HIV integration, the NHEJ DNA repair
pathway, did not appear prominent in our screen. These results
are consistent with those reported from previous genome scale
siRNA screens for HIV host factors, as well as an shRNA screen
carried out in a T-cell line, but inconsistent with a ribozyme-based
screen in which Ku80 knockdown decreased both retroviral
integration and tat-mediated transcription [5]–[7], [23]–[24]. The
role of the NHEJ process in HIV replication is suggested to be
Table 2. mRNA knockdown and effect on HIV infectivity of
39UTR-directed siRNAs targeting BER-pathway genes.
Targeted
Gene Targeted Sequence
mRNA Level
(% of Control)
HIV Infectivity
(% of Control)
APEX1 GCATTCTATTTCTCATGTA 11 28
ACCAGGCTCCTGTGATAGA 29 62
ACAAAGACTACTAATGACT 37 89
LIG3 GGCAGATAGACACAGTATA 28 102
CATACTCTCCTTTACCATA 23 54
CCTTTACCATACTACTGGA 43 25
MUTYH TGAGAATCCTGTTGTTAGT 48 43
CCTGAGAATCCTGTTGTTA 51 34
GAGAATCCTGTTGTTAGTA 39 26
NEIL2 ACGTCTAAGTGTCCAGAAA 11 113
CTGCTTGTTTACTCCTTAA 10 13
GGTGCCAGTAGTATAATAT 11 27
NTHL1 GAAGTGGCTTTACGCTTCA 65 36
AAGCCACGCCTGTTGAATA 15 48
GAAGCCACGCCTGTTGAAT 24 54
OGG1 GTATGCTCATTGAACTTTA 52 50
TAATTCGAGTCATGGCTAA 56 150
TTCGAGTCATGGCTAATTT 52 117
OGG1
(coding)
CAAAGTCCTGCACACTGGA 24 50
GTTACCCTGGCTCAACTGT 29 67
POLL CCTGACCAACGCTCCAATA 56 35
TGACTAGCTTGGCCAGTAG 69 32
TAGCTTGGCCAGTAGTCGA 73 50
The sequence of siRNAs directed against the 39UTR of six different BER enzymes
is shown, along with the amount of mRNA knockdown achieved in HeLa P4/R5
cells and the relative level of HIV infection in a single cycle assay relative to
transfection of a nonsilencing siRNA following transfection of the siRNA. siRNAs
in bold were used in the cDNA rescue experiments shown in Fig. 2.
doi:10.1371/journal.pone.0017612.t002
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or in circularizing unintegrated vDNA [25], [26], [10]–[12]. While
this may be essential for host cell viability, it is not clear that it is
essential for expression of retroviral genes, thus siRNA screens
designed with tat-mediated expression of a reporter gene may not
provide a reliable readout for factors involved in post-integration
DNA repair.
Transfecting HeLa P4/R5 cells with siRNAs targeting15 BER
genes reduced HIV infection in these cells by up to 70%,
seemingly by decreasing vDNA integration. One possible role for
BER enzymes in HIV integration may be in the repair of damaged
vDNA if damaged DNA is poorly bound or processed by HIV
integrase. An increase in the overall amount of damage in vDNA
could be consistent with the high level of variability we observed
when we measured vDNA levels to determine whether the BER
siRNAs had an effect on reverse transcription, as vDNA damage
would not be expected to be uniform and could have an effect on
primer binding in the rtPCR assays used for detection.
Alternatively, as HIV integration and BER protein complex
formation have both been more frequently associated with open
chromatin [27]–[29], a non-conflicting conjecture is that BER
enzyme complexes could target the PIC to the host chromosome
at sites of DNA damage.
This is the first report to identify a role for the short patch base
excision repair pathway in HIV replication, although individual
BER genes have been associated with HIV disease. HIV tat
upregulates expression of POLB and OGG1 [30]–[31], suggesting
the importance of these proteins for successful viral replication.
Individuals infected with HIV exhibit increased levels of
intracellular oxidative stress and oxidative damage as HIV
infection progresses to AIDS [32]. siRNA-mediated knockdown
of PARP1 was linked to a decrease in HIV integration [33].
Finally, siRNA-mediated knockdown of APEX1 was shown to
decrease HIV infection [34].
In summary, we conducted an siRNA screen to identify DNA
repair pathways important for HIV infection and identified BER
as being highly represented among targets of effective siRNAs. We
validated the role of 7 of the targeted BER genes in HIV
replication by rescuing the siRNA-mediated knockdown with
cDNA expression of the targeted gene, and extended the
observation further by showing that NEIL12/2, MUTYH2/2,
OGG12/2, and POLB2/2 cell lines are less effectively
transduced by HIV-based retroviral vectors. We explored the role
BER plays in HIV replication, and showed that when BER is
knocked down, HIV enters the cell, is reverse transcribed and
trafficked to the nucleus, but vDNA integration is decreased.
Further exploration of BER and its role in HIV replication could
lead to the identification of new host factor targets for
antiretroviral drugs.
Methods
Materials
HXB2 HIV was obtained from Advanced Biotechnologies
(Columbia, MD). siRNAs used in the screen were designed using
an algorithm developed to increase the targeting efficiency of the
siRNA while reducing off-target silencing [35]. siRNAs were
synthesized by Sigma-Proligo (The Woodlands, TX). The HIV
integrase inhibitor, L-870,810 was obtained from the MRL
compound collection [36].
siRNA Screen
HeLa P4/R5 cells [37] were transfected with pools of 3
siRNAs (Table S1) as described in [5]. Briefly, cells were plated in
96-well plates and transfected with 100 nM of the siRNA pools
using Oligofectamine (Invitrogen, Carlsbad, CA). Twenty-four
hours following transfection, cells were infected with HXB2 HIV.
Two uninfected wells of cells were included in each plate as a
Figure 2. Effect of 39UTR targeting siRNA on HIV infectivity and knockdown rescue by coexpression of cDNA. HeLa P4R5 cells were
cotransfected with siRNAs targeting the 39 UTR of the indicated gene and either an empty expression vector (grey bars) or a vector expressing the
cDNA for the targeted gene (striped bars). N=3, error bars indicate standard deviation. **p,0.01, *p,0.05 comparing empty vector and coexpressed
cDNA.
doi:10.1371/journal.pone.0017612.g002
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days after infection, b-galactosidase activity was assayed using
Gal-Screen (Applied Biosystems, Carlsbad, CA) as per the
manufacturer’s instructions. Background measurements were
subtracted from all wells, and b-galactosidase activity was
normalized to the activity measured with the nonsilencing
(luciferase) control siRNA. All transfections were conducted in
duplicate. Cell viability following siRNA transfection was
measured separately using Alamar Blue (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. siRNAs
targeting Cyclin T1 and CDK9 were included as positive
controls, while an siRNA targeting luciferase and a mock
transfection were included as negative controls.
cDNA Rescue
cDNAs encoding APEX1, LIG3, MUTYH, NEIL2, NTHL1,
POLL and OGG1 were purchased from Invitrogen (Carlsbad,
CA) and cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA).
siRNAs targeting the 39 UTR of the gene are described in Table 2.
siRNAs and the cDNA-expressing plasmid were co-transfected
into HeLa P4/R5 cells using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA). Cells were infected and assayed as described [5].
HIV Entry Assay
HeLa P4/R5 cells were transfected with siRNAs as described
above and in [5]. HeLa P4/R5 cells were plated in 96 well plates
and transfected with siRNAs using Oligofectamine (Invitrogen,
Carlsbad, CA). 24 h following transfection, the entry of HIV virus-
like particles was assayed. Media was removed and replaced with
media containing HIV virus-like particles containing b-lactamase
as described [20]. The virus-like particles were incubated with the
transfected cells for 3 h at 37C. The cells were then washed with
phenol red-free DMEM. CCF4-AM from GeneBlazer (Invitrogen,
Carlsbad, CA) was added to each well to a final concentration of
5 mM. Cells were incubated with the CCF4-AM b-lactamase
substrate overnight at room temperature in the dark. b-lactamase
activity was measured the following day as an measurement of
viral entry as it indicates the delivery of the contents of the virus-
like particle into the cell. Activity was measured by reading
fluorescence with excitation at 405 nm and emission at 460 nm
(detects cleaved CCF4-AM substrate), or 535 nm (uncleaved
CCF4-AM).
HIV-Tat Assay
The assay for evaluating tat-mediated transactivation through
the HIV-LTR was conducted as described [5]. HeLa P4/R5 cells
were plated into 96-well plates and transfected with siRNAs at a
final concentration of 100 nM using Oligofectamine (Invitrogen,
Carlsbad, CA). The following day, the cells were transfected with
pUCd5-Tat, an HIV1-tat expression vector, using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
instructions. The following day, b-galactosidase activity induced
by the expression of HIV1-tat was detected using Lysis buffer plus
substrate (25:1) (Applied Biosystems) and measured using a
VictorLight luminometer (PerkinElmer).
Figure 3. MEFs lacking BER genes have decreased transduction
by HIV-based retroviral vectors. MEFs derived from mice with
deletions of the Neil1, Myh, Ogg1, Polb, or a double deletion of Myh and
Ogg1 genes. Cells were transduced with an HIV retroviral vector
expressing GFP and analyzed at 72 hours post-infection by flow
cytometry for GFP expression indicating successful infection. The
percentage of GFP positive cells is shown relative to wild type MEFs
from matched littermates. (A) Wild type, Neil12/2, Myh2/2, Ogg12/2,
Myh2/2 Ogg12/2, and Polb 2/2 (PolB2/2) cell lines, (B) Wild type
(Neil1+/+), heterozygous (Neil1+/2), and Neil12/2 cell lines. Infections
were performed at two MOI in duplicate at least three times. Error bars
indicate the standard deviation after normalization.
doi:10.1371/journal.pone.0017612.g003
Table 3. Effect of siRNAs targeting BER enzymes on HIV entry,
reverse transcription, and tat-mediated transcription.
Targeted Gene
Viral Entry
(% Inhibition)
Reverse
Transcription
(% Inhibition)
Tat-mediated
Transcription
(% Inhibition)
APEX1 964N D 1 2 63
LIG3 564N D 1 2 63
MUTYH 3624 2 638 1466
NEIL1 162N D 1 9 65
NEIL2 1063N D 1 2 67
NEIL3 4628 632 1463
NTHL1 9642 2 626 1365
OGG1 663N D 1 4 67
POLB 6624 681 8 62
POLL 265N D 1 6 63
CD4 7961N D 1 6 65
CXCR4 6762N D 2 1 62
Cyclin T1 ND ND 6464
LUC 0 0 0
doi:10.1371/journal.pone.0017612.t003
HIV DNA Repair siRNA Screen Reveals Role for BER
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17612qPCR analysis
For mRNA measurements, total cellular RNA was purified
using RNeasy Plus (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. mRNA levels were then determined
by qrtPCR using primer and probe sets designed and synthesized
by Applied Biosystems (Foster City, CA) and mRNA levels were
normalized to cyclophilin.
For evaluating reverse transcription and integration of viral
RNA: HeLa P4/R5 cells were plated in 6 well culture plates, and
transfected with siRNA at a final concentration of 100 nM using
Oligofectamine (Invitrogen, Carlsbad, CA) as described above and
in [5]. The following day, the cells were infected with HXB2 HIV
as described. DNA was extracted 48 hours after infection using
DNeasy (Qiagen, Valencia, CA). HIV reverse transcribed or
integrated vDNA was measured using Applied Biosystems 7500
Fast Real-Time PCR System and primer and probe sets essentially
as described [21].
vDNA production was quantified using the 5NCR forward
primer 59GGCTAACTAGGGAACCCACTGCTT-39, the 5NCR
reverse primer 59-AGCCGAGTCCTGCGTCG-39, and the
5NCR probe 59-(FAM)-CCTCAATAAAGCTTGCCTTGAG-
TGCTTCAA-(TAMRA)-39. The qPCR reaction was initiated by
2 minutes at 50 C, followed by 95 C for 5 minutes, and then 45
cycles of 95 C for 15 seconds followed by 60 C for 1 minute.
Integrated vDNA was quantified using the Alu/LTR forward
primer 59-AACTAGGGAACCCACTGCTTAAG-39, the Alu/
LTR reverse primer 59-TGCTGGGATTACAGGCGTGAG-39 ,
and the Alu/LTR probe 59-(FAM)-ACACTACTTGAAGCACT-
CAAGGCAAGCTTT-(TAMRA)-39. The qPCR reaction was
initiated by 2 minutes at 50 C, followed by 95 C for 5 minutes,
and then 45 cycles of 95 C for 15 seconds followed by 60 C for
1 minute 30 seconds.
HIV vector transduction of BER deletion cell lines
HIV vector particles expressing GFP following integration were
generated by cotransfecting HEK293T (ATCC, Manassas, VA)
cells with a VSVG envelope protein expression vector, a
packaging vector, and a plasmid expressing genomic HIV RNA
including a CMV promoter that drives expression of GFP as
described [38]. At 72 hpi, cells were analyzed by flow cytometry
for GFP expression. The retroviral particles were collected from
the cell media, filtered to remove cells, and treated with DNAse to
remove plasmid and cellular DNA. Mouse embryonic fibroblasts
with deletions of Mutyh, Ogg1, Neil1, or PolB have been
described [16]–[19]. Cells were infected with the retroviral vector,
incubated for 72 h, fixed with paraformaldehyde, and analyzed for
GFP expression by flow cytometry (BD FACS Calibur and
CellQuest software). The relative level of GFP expressing cells was
normalized to cells from wildtype littermates.
Supporting Information
Table S1 Data from the targeted HIV infectivity screen.
Transcript ID refers to the accession number for the mRNA
transcript against which the siRNAs were designed. The Gene
Name column contains the gene symbol for the targeted gene. The
‘‘Pool siRNA #1 sense sequence’’, ‘‘Pool siRNA #2 sense
Figure 4. Knockdown of BER genes has no effect on nuclear
localization, but does decrease HIV integration. (A). Effect on
2LTR circle formation. HeLa P4/R5 cells were transfected with the
indicated siRNAs and treated with the integrase inhibitor L-870,810 to
increase 2LTR circle formation (striped bars) or left untreated (solid
bars), and infected with HIV-1. 2LTR circles were measured as in (21). (B).
Effect of BER gene knockdown on HIV integration. HeLa P4/R5 cells
were transfected with siRNAs targeting BER genes or a negative control
siRNA targeting Luciferase. Cells were infected with HIV-1, DNA was
isolated, and Alu-LTR PCR was conducted to determine the relative
amount of integrated HIV-1 vDNA.
doi:10.1371/journal.pone.0017612.g004
Figure 5. Venn Diagram of the DNA repair genes identified as
important for HIV infection in three genome scale siRNA
screens compared with this work.
doi:10.1371/journal.pone.0017612.g005
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contain the sense strand sequences for each of the siRNAs in the
pool used in the screen. The ‘‘Average activity (% of lucif)’’
column contains the HIV infectivity data for HeLa P4/R5 cells
transfected with the indicated siRNA pool normalized to the two
nonsilencing (luciferase-targeting) controls included in the same
96-well plate. The average of two separate experiments is shown.
The final column, ‘‘siRNA Toxicity’’ indicates whether cell
toxicity was observed in parallel transfections with the siRNA
pool. siRNA pools causing toxicity are indicated with a ‘‘YES’’ in
this column. siRNAs that caused toxicity and those that did not
decrease HIV infectivity by more than 40% were not studied
further, and this is indicated by shading these rows gray.
(XLS)
Table S2 Key to assignment of hits in Figure 1B. Hits
assigned to BER, NER, NHEJ, DSB, MMR, HR, SSBR, or other
from the primary screen are listed. Additional BER enzymes for
which two or more effective single siRNAs were identified are
listed in italics below the list from the primary screen.
(XLS)
Author Contributions
Conceived and designed the experiments: ASE KY DH RF HZ.
Performed the experiments: QH MX KY HZ. Analyzed the data: ASE
RF DH KY HZ. Contributed reagents/materials/analysis tools: QH MX
KY HZ. Wrote the manuscript: ASE KY DH RF.
References
1. Go ¨tte M, Li X, Wainberg MA (1999) HIV-1 reverse transcription: a brief
overview focused on structure-function relationships among molecules involved
in initiation of the reaction. Arch Biochem Biophys 365: 199–210.
2. Turlure F, Devroe E, Silver PA, Engelman A (2004) Human cell proteins and
human immunodeficiency virus DNA integration. Front Biosci 9: 3187–3208.
3. Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and
potential as therapeutics. Nat Rev Drug Discov 3: 318–329.
4. Moffat J, Sabatini DM (2006) Building mammalian signaling pathways with
RNAi screens. Nat Rev Mol Cell Biol 7: 177–187.
5. ZhouH,XuM,HuangQ,GatesAT,ZhangXD,etal.(2008)Genome-scaleRNAi
screen for host factors required for HIV replication. Cell Host Microbe 4: 495–504.
6. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008)
Identification of host proteins required for HIV infection through a functional
genomic screen. Science 319: 921–926.
7. Ko ¨nig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global
analysis of host-pathogen interactions that regulate early-stage HIV-1 replica-
tion. Cell 135: 49–60.
8. Robertson AB, Klungland A, Rognes T, Leiros I (2009) DNA repair in
mammalian cells: Base excision repair: the long and short of it. Cell Mol Life Sci
66: 981–993.
9. Daniel R, Katz RA, Skalka AM (1999) A role for DNA-PK in retroviral DNA
integration. Science 284: 644–647.
10. Daniel R, Greger JG, Katz RA, Taganov KD, Wu X, et al. (2004) Evidence that
stable retroviral transduction and cell survival following DNA integration
depend on components of the nonhomologous end joining repair pathway.
J Virol 78: 8573–8581.
11. Kilzer JM, Stracker T, Beitzel B, Meek K, Weitzman M, et al. (2003) Roles of
host cell factors in circularization of retroviral DNA. Virology 314: 460–467.
12. Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, et al. (2001) Role of the
non-homologous DNA end joining pathway in the early steps of retroviral
infection. EMBO J 20: 3272–3281.
13. Sancar A, Lindsey-Boltz L-A, U ¨nsal-Kac ¸maz K, Linn S (2004) Molecular
Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints.
Annu Rev Biochem 73: 39–85.
14. Friedberg EC, Walker GC, Siede W (1995) DNA Repair and Mutagenesis.
Washington, DC: American Society of Microbiology Press.
15. Yoder KE, Bushman FD (2000) Repair of gaps in retroviral DNA integration
intermediates. J Virol 74: 11191–11200.
16. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, et al. (1999)
Accumulation of premutagenic DNA lesions in mice defective in removal of
oxidative base damage. Proc Natl Acad Sci U S A 96: 13300–13305.
17. Xie Y, Yang H, Cunanan C, Okamoto K, Shibata D, et al. (2004) Deficiencies
in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations
in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 64: 3096–
3102.
18. Vartanian V, Lowell B, Minko IG, Wood TG, Ceci JD, et al. (2006) The
metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.
Proc Natl Acad Sci U S A 103: 1864–1869.
19. Sobol RW, Horton JK, Ku ¨hn R, Gu H, Singhal RK, et al. (1996) Requirement
of mammalian DNA polymerase-beta in base-excision repair. Nature 379:
183–186.
20. Tobiume M, Lineberger JE, Lundquist CA, Miller MD, Aiken C (2003) Nef
does not affect the efficiency of human immunodeficiency virus type 1 fusion
with target cells. J Virol 77: 10645–10650.
21. Butler SL, Hansen M, Bushman FD (2001) A quantitative assay for HIV DNA
integration in vivo. Nat Med 7: 631–634.
22. Hazuda DJ, Felock P, Witmer M, Wolfe A, Stillmock K, et al. (2000) Inhibitors
of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Science 87: 646–650.
23. Waninger S, Kuhen K, Hu X, Chatterton JE, Wong-Staal F, et al. (2004)
Identification of cellular cofactors for human immunodeficiency virus replication
via a ribozyme-based genomics approach. J Virol 78: 12829–12837.
24. Yeung ML, Houzet L, Yedavalli VS, Jeang KT (2009) A genome-wide short
hairpin RNA screening of jurkat T-cells for human proteins contributing to
productive HIV-1 replication. J Biol Chem 284: 19463–19473.
25. Daniel R, Marusich E, Argyris E, Zhao RY, Skalka AM, et al. (2005) Caffeine
inhibits human immunodeficiency virus type 1 transduction of nondividing cells.
J Virol 79: 2058–2065.
26. Smith JA, Daniel R (2006) Following the path of the virus: the exploitation of
host DNA repair mechanisms by retroviruses. ACS Chem Biol 1: 217–26.
27. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, et al. (2004) Retroviral
DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
PLoS Biol 2: E234.
28. Schro ¨der AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2002) HIV-1
integration in the human genome favors active genes and local hotspots. Cell
110: 521–529.
29. Amouroux R, Campalans A, Epe B, Radicella JP (2010) Oxidative stress triggers
the preferential assembly of base excision repair complexes on open chromatin
regions. Nucleic Acids Res 38: 2878–2890.
30. Srivastava DK, Tendler CL, Milani D, English MA, Licht JD, et al. (2001) The
HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair
enzyme beta-polymerase. AIDS 15: 433–40.
31. Imai K, Nakata K, Kawai K, Hamano T, Mei N, et al. (2005) Induction of
OGG1 gene expression by HIV-1 Tat. J Biol Chem 280: 26701–26713.
32. Aukrust P, Luna L, Ueland T, Johansen RF, Mu ¨ller F, et al. (2005) Impaired
base excision repair and accumulation of oxidative base lesions in CD4+ T cells
of HIV-infected patients. Blood 105: 4730–4735.
33. Kameoka M, Nukuzuma S, Itaya A, Tanaka Y, Ota K, et al. (2004) RNA
interference directed against Poly(ADP-Ribose) polymerase 1 efficiently
suppresses human immunodeficiency virus type 1 replication in human cells.
J Virol 78: 8931–8934.
34. Yan N, Cherepanov P, Daigle JE, Engelman A, Lieberman J (2009) The SET
complex acts as a barrier to autointegration of HIV-1. PLoS Pathog 5:
e1000327.
35. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. (2003)
Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol
21: 635–637.
36. Hazuda DJ, Anthony NJ, Gomez RP, Jolly SM, Wai JS, et al. (2004) A
naphthyridine carboxamide provides evidence for discordant resistance between
mechanistically identical inhibitors of HIV-1 integrase. Proc Natl Acad Sci U S A
101: 11233–11238.
37. Clavel F, Charneau P (1994) Fusion from without directed by human
immunodeficiency virus particles. J Virol 68: 1179–1185.
38. Yoder K, Espeseth A, Russo MT, Lloyd RS, Hazuda D, et al. (2010) The host
base excision repair pathway is required for efficient lentivirus integration. PLOS
One.In Press.
HIV DNA Repair siRNA Screen Reveals Role for BER
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17612